Digestinol

Digestinol sells a single-ingredient dietary supplement based on the Aloe mucilaginous polysaccharide (AMP) extract of the Aloe vera leaf. The line consists of two SKUs: Digestinol capsules (90-count) and Digestinol powder (30-day canister), both priced at $149 per unit, placing the brand in the premium tier. Sales are direct-to-consumer through the company’s own website; no retail or third-party e-commerce listings are used. The brand’s core claim is that the proprietary AMP molecule survives stomach acid and binds to inflamed tissue along the entire GI tract, providing relief for IBS, Crohn’s, colitis, GERD and diverticulitis without drugs or stimulants. Every order ships with a 90-day empty-bottle money-back guarantee and a printed “success guide” that outlines a staged dosage protocol, positioning Digestinol as a medical-food alternative rather than a casual probiotic. Customers are typically adults 35-65 who have cycled through prescription gastroenterology drugs, elimination diets and conventional probiotics without sustained symptom control. They value drug-free, plant-derived solutions and are willing to pay upfront for a single high-potency ingredient if it promises to reduce flare-ups and doctor visits. Digestinol competes in the clinical-grade gut-health segment against condition-specific supplements that combine multiple strains, enzymes or herbal blends. It differentiates by isolating one patented Aloe extract, publishing third-party LPS endotoxin tests for purity, and refusing subscription models—relying instead on one-time purchases and word-of-mouth reflux from closed Facebook patient groups.